About

Sanofi Mexico’s in-house legal team provides expert guidance to the pharmaceutical and vaccine manufacturer’s Mexican operations which include the production of medicines, vaccines, and pharmaceutical products for distribution across its global market.
In 2017, Sanofi and Boehringer Ingelheim completed a business swap arrangement with Sanofi’s animal health subsidiary in Mexico, and Merial, for Boehringer’s consumer healthcare business. This complex deal took significant consultation from Sanofi’s legal department to accomplish.